International Clinical Trials in Psychiatry/Psychology

Austria

• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Wien; Research Site:
  
  

Brazil

• Depression (Major/Severe): A Study of Ixel (Milnacipran) in Patients With Major Depression Not Responding to SSRIs.
  Botucatu; Research Site:
  
  
• Depression (Major/Severe): A Study of Ixel (Milnacipran) in Patients With Major Depression Not Responding to SSRIs.
  Porto Alegre; Research Site:
  
  
• Depression (Major/Severe): A Study of Ixel (Milnacipran) in Patients With Major Depression Not Responding to SSRIs.
  Santo Andre; Research Site:
  
  
• Depression (Major/Severe): A Study of Ixel (Milnacipran) in Patients With Major Depression Not Responding to SSRIs.
  Sao Paulo; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Pelotas; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Rio De Janeiro; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Salvador; Research Site:
  
  

Canada

• Depression: Are you persistently sad? Do you lack the energy and motivation to do things you once enjoyed? Do you feel hopeless? You may be suffering from depression.
  Kelowna, BC; Okanagan Clinical Trials
  
  
• Depression: Clinical research study of an investigational oral drug for the treatment of moderate to severe major depressive disorder
  Edmonton, Alberta; Grey Nuns Community Hospital
  
  
• Depression: Clinical research study of an investigational oral drug for the treatment of moderate to severe major depressive disorder
  Miramichi, NB; Miramichi Regional Health Authority
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  London, Ontario; London Health Sciences Center University Campus
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Montreal, Quebec; Notre Dame
  
  
• Schizophrenia and Schizoaffective Disorders: Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
  Montreal, QUEBEC; Institut Allan Memorial
  
  

Chile

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  San Miguel, Santiago; Complejo Asistencial Barros Luco
  
  

Colombia

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Bogota; Asociacion Medica De Los Andes
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Bucaramanga; Fundacion Cardiovascular del Oriente Colombiano
  
  

France

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Lille cedex; C.H.R.U de Lille, Hopital R. Salengro Service de Neuroligie A
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Marseille Cedex 05; A.P. Marseille, Hopital de la Timone
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Nantes Cedex 1; C.H.R.U de nantes Hopital Guillaume et Rene Laenn
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Marseille; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Orvault; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Toulon; Research Site:
  
  

Germany

• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Achim; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Bochum; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Freiburg; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Hamburg; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Nürnberg; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Westerstede; Research Site:
  
  

Guatemala

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Zona 14; Unidad de Diagnostico Cardiologico
  
  

Hong Kong

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Shatin, New Territories; U. of Hong Kong, Shatin- Prince of Wales Hospital
  
  

Hungary

• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Balassagyarmat; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Budapest; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Gyor; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Nyíregyháza; Research Site:
  
  

Italy

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Chieti Scalo; Centro Studi L’invecchiamento Oncology and Neuroscience
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Milano; Istituti Clinici di Perfezionamento
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Pavia; IRCCS Istituto Neurologico “C Mondino
  
  

Japan

• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Aichi; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Chiba; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Fukuoka; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Hiroshima; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Hokkaido; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Nagasaki; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Niigata; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Osaka; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Tokushima; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Tokyo; Research Site:
  
  

Mexico

• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Mexico City; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Monterrey; Research Site:
  
  

Peru

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  La Victoria, Lima; Hospital Nacional Guiillermo Almenarea Irigoyen
  
  

Poland

• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Bydgoszcz; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Skorzewo; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Torun; Research Site:
  
  
• Schizophrenia and Schizoaffective Disorders: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
  Tuszyn; Research Site:
  
  

Portugal

• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Coimbra; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Porto; Research Site:
  
  

Singapore

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Singapore; National Neuroscience Institute: Dept. of Neurology
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Singapore; Singapore General Hospital, Department of Neurology
  
  

South Africa

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Pretoria, Gauteng; willows MR Medical Center
  
  

Spain

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Barcelona; Hospital de la Santa Creu i de Sant Pau
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Madrid; Hospital Gregorio Maranon
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Madrid; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Santander; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Santiago; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Valladolid; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Vitoria; Research Site: